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Abstract
Background: Several systematic reviews have shown that additional exercise therapy has a positive effect on
functional outcome after stroke. However, there is an urgent need for resource-efficient methods to augment
rehabilitation services without increasing health care costs. Asking informal caregivers to do exercises with their
loved ones, combined with e-health services may be a cost-effective method to promote early supported discharge
with increased functional outcome.
The primary aim of the CARE4STROKE study is to evaluate the effects and cost-effectiveness of a caregiver-mediated
exercises program combined with e-health services after stroke in terms of self-reported mobility and length of stay.
Methods: An observer-blinded randomized controlled trial, in which 66 stroke-patients admitted to a hospital stroke
unit, rehabilitation center or nursing home are randomly assigned to either 8 weeks of the CARE4STROKE program in
addition to usual care (i.e., experimental group) or 8 weeks of usual care alone (i.e., control group). The
CARE4STROKE program is compiled in consultation with a trained physical therapist. A tablet computer is
used to present video-based exercises for gait and gait-related activities in which a caregiver acts as an
exercise coach.
Primary outcomes are the mobility domain of the Stroke Impact Scale and length of stay. Secondary outcomes are the
other domains of the Stroke Impact Scale, motor impairment, strength, walking ability, balance, mobility, (Extended)
Activities of Daily Living, psychosocial functioning, self-efficacy, fatigue, health-related quality of life of the patient as
well as the experienced strain, psychosocial functioning and quality of life of the caregiver. An economic evaluation will
be conducted from the societal and health care perspective.
Discussion: The main aspects of the CARE4STROKE program are 1) increasing intensity of training by doing exercises
with a caregiver in addition to usual care and 2) e-health support. We hypothesize this program leads to better
functional outcome and early supported discharge, resulting in reduced costs.
Trial registration: The study is registered in the Dutch trial register as NTR4300, registered 2 December 2013.
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Background
Stroke poses major social and healthcare problems
worldwide. The prevalence of stroke is increasing [1]. In
2010, the absolute numbers worldwide of people with
first stroke (169 million), stroke survivors (33 million),
stroke-related deaths (59 million), and DALYs lost (102
million) were high and had significantly increased since
1990. About 28 % of stroke patients remain dependent
in basic activities of daily living (ADL) such as dressing,
toileting and/or indoor mobility at twelve months after
stroke [2]. Although the main target of stroke rehabilita-
tion is to reduce long term dependency and allow pa-
tients to return to their own community [3], only 60 %
of the stroke patients can ultimately walk independently
with or without assistive devices in the community [4].
In the 27 EU countries, total annual cost of stroke is
estimated at €27 billion: €18.5 billion (68.5 %) for direct
and €8.5 billion (31.5 %) for indirect costs. A further
sum of €11.1 billion is calculated for the value of infor-
mal care [5]. The already overstretched health resources
worldwide emphasize the need for early supported dis-
charge (ESD) of stroke patients [3, 6], because a large
part of the stroke care costs are spent on inpatient re-
habilitation services [7, 8].
A large number of stroke patients are using inpatient ser-
vices because they are not safe and independent in their
mobility. ESD is enabled as soon as these patients are safe
and independent in their transfers and gait, suggesting that
ESD heavily depends on improvement of standing balance
and motor control of the lower limbs [3, 9].
A number of meta-analyses show that intensity of
training and repetitive task training are crucial aspects
of stroke rehabilitation, concluding that more exercise
therapy improves outcomes [3, 10–16]. Guidelines rec-
ommend that patients admitted to a rehabilitation facil-
ity should have the opportunity to receive a daily dose of
45 min of exercise therapy in the first 3 months after
stroke [15, 17–20]. However, most patients admitted to
hospital stroke units, rehabilitation centers or nursing
homes are physically inactive or involved in activities
that contribute little to their recovery [21–23]. A recent
survey in the Netherlands of 91 hospital stroke units
showed that patients receive on average about 24 min of
exercise therapy each working day [24].
Acknowledging that the resources (mostly staff ) in re-
habilitation settings are limited, novel methods to in-
crease the intensity of exercise therapy with minimal use
of resources are needed [3, 24]. One such novel method
could be to actively involve caregivers in mediating exer-
cises. In particular when caregiver-mediated exercises
(CME) are combined with e-health/tele-rehabilitation
services, easy contact with, and monitoring by the re-
habilitation team is promoted [25]. This way, CME en-
hances ESD by providing a smoother transition from
inpatient setting to the home situation. And CME can
continue in the community setting.
Recently, Galvin et al. found favorable effects of CME
on functional outcome in stroke patients and on perceived
strain by caregivers [26]. In addition, we hypothesize,
CME might contribute to improved feelings of quality of
life (QOL) and empowerment for both patient and care-
giver by providing them with more knowledge about the
capabilities of the stroke patient.
Few randomized controlled trials (RCTs) have investi-
gated CME and their quality is heterogeneous [26–31]. In
addition, CME has not been combined with e-health facil-
ities to promote self-management and empowerment of
patient and caregiver, whereas studies investigating cost-
effectiveness of CME after stroke are still lacking.
The aim of the current paper is to describe the
CARE4STROKE study design. The CARE4STROKE study
aims to evaluate the effects and cost-effectiveness of a
CME program combined with e-health, added to usual
care in hospital stroke units, rehabilitation centers and
nursing homes. We hypothesize that the CARE4STROKE
program will lead to better self-reported mobility and re-
duced length of inpatient stay (LOS) in stroke patients
compared to usual care, resulting in reduced costs.
Methods
Design
This study is an observer-blinded, multicenter random-
ized controlled trial with an economic evaluation along-
side. The trial will be conducted by trained therapists of
the participating centers. Within each type of setting,
patients will be randomly allocated to either CME com-
bined with e-health services (CARE4STROKE) in addition
to usual care or to usual care alone. The study is registered
in the Dutch trial register as NTR4300, registered 2
December 2013.
Setting
The study will take place in hospitals (stroke unit and
outpatient clinic), rehabilitation centers and rehabilita-
tion departments of nursing homes in the Netherlands.
A trained researcher, blinded to group allocation, will
visit the participants in the center of admission for
obtaining informed consent and conducting measure-
ments during the study.
Reade Rehabilitation Center and VU University Medical
Center are the initiators of this study. The study protocol
is approved by the Medical Ethics Review Committee of
the Slotervaart Hospital and Reade and is registered with
the trial number: NL34618.048.12.
Participants
Sixty-six patients with a first-ever or recurrent stroke,
who are admitted to one of the participating centers and
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their caregivers, will be recruited for this study. Stroke is
defined by the World Health Organization as "a clinical
syndrome typified by rapidly developing signs of focal or
global disturbance of cerebral functions, lasting more
than 24 h or leading to death, with no apparent causes
other than of vascular origin" [32]. A caregiver is defined
as someone close to the patient, who is willing and able
to do exercises together with the patient, for example a
partner, family member or friend. This caregiver is not a
professional and is not paid for his/her efforts.
Inclusion criteria for both patient and caregiver are:
(1) 18 years or older, (2) written informed consent, (3)
able to understand the Dutch or English language (on a
sufficient level to understand instructions on CME and
e-health application), (4) motivated for CME, (5) a score
of <11 on the domain ‘depression’ on the Hospital
Anxiety and Depression Scale (HADS) [33, 34].
Additional inclusion criteria for the patient are: (1)
willing and able to appoint a caregiver who wants to par-
ticipate in the program (with a maximum of two care-
givers), (2) living independently before the stroke, (3)
planned to be discharged home, (4) being able to follow
instructions (MMSE score > 18 points) [35], (5) Functional
Ambulation Score (FAC) < 5 [36].
Additional inclusion criteria for the caregiver are: 1)
being medically stable and 2) physically able to perform
the exercises together with the patient.
Exclusion criterion for both patient and caregiver will
be serious comorbidity, which interferes with mobility
training. Patients will be excluded when they, for ex-
ample, have another neurological disease like Multiple
Sclerosis or Parkinson disease, fractures or congestive
heart failure. Caregivers will be excluded when they are
not able to walk 100 metres, stand and/or keep their
balance.
To determine suitability in terms of safety, cognition
and communication skills of both patient and partner,
an intake exercise session with one of the trained phys-
ical therapists is scheduled prior to inclusion. This ther-
apist checks the inclusion/exclusion criteria and judges
if the exercises can be done adequately and safely. Rea-
sons of exclusion will be recorded.
Baseline characteristics
Patient characteristics at baseline will be recorded from
the medical status. These include demographics (age,
gender), type of stroke, time post stroke, hemiplegic side,
somato-sensory deficits (yes/no), homonymous hemian-
opia (yes/no), visuo-spatial neglect (yes/no), aphasia
(yes/no) and comorbidity following the Cumulative Ill-
ness Rating Scale (CIRS) [37]. Characteristics of the
caregiver that will be recorded are: demographics (age,
gender), relation to patient, work and existing comor-
bidities following the CIRS.
Study procedures
Patients will be stratified by type of participating center
(hospital stroke unit, rehabilitation center or nursing
home) and subsequently randomized, by an independent
researcher blinded for patient characteristics, to the con-
trol or the experimental group. An online randomization
procedure with a minimization algorithm is used to pre-
vent unequal group sizes [38]. Patients will start imme-
diately after admission, continue for 8 weeks irrespective
of time of discharge and will be followed-up until 12
weeks after randomization. Outcomes will be measured
at baseline, 8 and 12 weeks (see Fig. 1: Study design).
Outcomes are either self-reported by patients and care-
givers (not blinded) or measured by an independent
observer who is blinded for treatment allocation. A self-
reported (cost) diary will be kept during the intervention
period to monitor compliance and to collect relevant
cost-data.
CARE4STROKE intervention
The CARE4STROKE program consists of 8 weeks of exer-
cise therapy executed with a caregiver, in addition to usual
care. A total of 37 standardized exercises were developed
that are aimed at improving mobility skills related to walk-
ing like, standing, turning and making transfers, or are
supporting exercises to improve mobility, strength and
(sitting) balance. Subsequently, exercises can be combined
into a patient-tailored, weekly progressive and incremental
training regimen. All exercises were developed in collabor-
ation with rehabilitation specialists (movement scientists,
physical therapists and physicians) and have been shown
feasible in a pilot study.
The exercises are presented as instructional videos in
an e-health application (‘app’) on a tablet computer. All
exercises are explained by a voice over. Regular re-
minders to exercise can be set in the app. The patients
and their caregivers are asked to perform the selected
set of exercises minimally five times per whole week for
30 min. Patients and caregivers are in particular advised
to do the exercises during the weekends, acknowledging
that patients are often physically inactive during the
weekend. When the intervention is correctly performed
patients will thus have a surplus of 150 min of caregiver-
mediated exercise training during a whole week.
During the intervention period patients and their care-
givers will have a weekly session with one of the trained
physical therapists. In these sessions, the set of exercises
performed in the previous week is evaluated and adapted
in a progressive manner. The participating couple is sub-
sequently instructed as to which set of exercises should
be performed during the next week. To make sure exer-
cises are correctly performed, the therapist will give
instructions about the new exercises and the patient-
caregiver couple will be asked to do these exercises in
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the presence of the therapist during this session. The
therapist will register all planned exercises and also if
any adverse event happened during the last week. Fur-
thermore, patient - caregiver couples are encouraged to
contact the coordinating therapist through telephone,
skype or email when appropriate.
The CARE4STROKE program starts when the patient is
admitted to one of the participating centers. When the
discharge date of the patient is earlier than the anticipated
end date of the CME program, the CME program con-
tinues at home with the continuity of the use of the app,
the weekly sessions with the therapist and the possibility
to contact the therapist through tele-rehabilitation ser-
vices when appropriate.
Usual care
The participants in the control group will receive usual
care according to the Guidelines of Physical Therapy for
patients with stroke of the Royal Dutch Physical Therapy
Association KNFG [15].
Compliance
In order to conduct this trial uniformly in the different
centers, all participating therapists will be thoroughly
trained in a training course before they start delivering
the program. Each therapist will be informed about 1)
the aims, design and measurements of the CARE4S-
TROKE study, 2) the in- and exclusion criteria, 3) the
CARE4STROKE program: the standardized program
and the possibilities to customize the CME, 4) their role
in the intake exercise session and following exercise ses-
sions, 5) how to fill in the diaries, 6) the use of the app.
Regular retraining sessions will be organized for the par-
ticipating therapists. A researcher (RN) will monitor if
the intervention is implemented appropriately in the
participating centers.
A self-reported diary will measure compliance of patient
and caregiver with the CME program.
Outcome measures
Primary outcome measures are the mobility domain of
the Stroke Impact Scale (SIS 3.0) and LOS.
Stroke Impact Scale (SIS) version 3.0, Mobility domain
The SIS is a self-reported, stroke specific measure that
includes 59 items and assesses eight domains related to
activities and participation. The mobility domain of the
SIS includes questions about patients’ perceived compe-
tence to walk, keep balance, and move around in their
own community. Each item is scored from ‘not difficult
at all’ to ‘cannot do at all’ on a 5-point scale. The SIS has
shown excellent clinimetric properties in English, as well
as in the Dutch translation [39–43].
Length of Stay (LOS)
LOS will be defined as the number of days of inpatient
stay in a rehabilitation facility and/or hospital setting,
from the day of admittance until the day of discharge.
Mean length of stay for each setting will be determined.
Possible reasons for an extended inpatient stay, like
medical complications or time needed for the realisation
of facilities at home, will be recorded.
Secondary outcomes
* Patient
Stroke Impact Scale, other seven domains The other
self-reported domains of the SIS will be assessed as sec-
ondary outcome measures.
Fugl Meyer (FM) motor score of lower extremity The
FM will be used to assess motor impairment. It is a reli-
able and valid motor performance test and evaluates the
ability to make movements outside the synergistic move-
ment pattern [44].
Motricity Index (MI), lower extremity The MI is a
valid and reliable measure of the strength of the lower
Fig. 1 Study design. R = Randomization. 1 = Measurement 1, baseline, before start of the intervention. 2 = Measurement 2, end of intervention
(eight weeks post randomization). 3 = Measurement 3, follow up (twelve weeks post randomization)
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extremity. Scores range from 0 (no activity) to 33 (max-
imum muscle force) for each dimension [45].
Six minute walking test Gait performance and endur-
ance will be assessed by the six minute walking test
[46, 47]. The walking distance covered in six minutes
will be recorded.
Ten meter walking test Gait speed will be measured by
the ten meter walking test. Comfortable walking speed
will be assessed. The mean of three repeated walking
speed measurements will be calculated [46, 47].
Timed up and go test (TUG) The TUG is a test of
basic functional mobility. The participant is asked to rise
from an armchair, walk three metres as fast as possible,
cross a line, turn, walk back and sit down again. The
time to complete this test will be recorded [46, 47].
Berg Balance Scale (BBS) Balance will be evaluated by
the BBS. BBS is a widely used clinical test of a person's
static and dynamic abilities. There are 14 items scored
from 0–4 (maximum), with a total score of 56. The BBS
is a valid and reliable measure [48, 49].
Rivermead Mobility Index (RMI) The RMI is a test to
evaluate functional mobility. It consists of 14 questions and
one observation (of balance) covering aspects from turning
in bed to running. The questions are scored dichotomously.
The RMI is valid, reliable and responsive [50–52].
Barthel Index (BI) The BI is an ordinal scale to meas-
ure performance in activities of daily living (ADL). It
uses ten variables describing ADL and mobility. A higher
score indicates higher independence in ADL. It has ex-
cellent clinimetric properties and can also be filled out
by an experienced nurse or relative [53].
Nottingham Extended ADL scale (NEADL) The
NEADL is a self reported questionnaire on activities ac-
tually performed. It consists of 22 items in four domains
(mobility, kitchen, domestic, leisure). Each item is rated
by one of four responses (able, able with difficulty, able
with help, unable). The NEADL has proved to be a reliable
and valid outcome measure in patients with stroke [54].
Modified Rankin Scale (MRS) The MRS is a measure
for the degree of disability or dependence in the daily ac-
tivities. The score runs from 0–6, ranging from perfect
health without symptoms to death. The score will be
dichotomised to good outcome (0–2) or poor outcome
(3–6). It is a valid scale and frequently used in stroke
outcome studies [55].
EuroQol (EQ-5D) The EQ-5D measures health related
quality of life. It consists of a self-assessment question-
naire about current health in five dimensions (mobility,
self-care, usual activities, pain/discomfort and anxiety/
depression) and a VAS score in which a person is asked
to rate their own health status. It is a widely used generic
questionnaire, which is validated for people with stroke. By
combining the questionnaire and VAS score a health state
is described, and each health state combined with popula-
tion estimates can be transformed to a utility. A utility is
an expression of the Quality Adjusted Life Years (QALY)
and can be used in economic evaluations [56–59].
* Caregiver
Expanded Caregiver Strain Index (CSI+) The CSI+
evaluates experienced strain of the caregiver. There are
18 items answered with ‘yes’ or ‘no’ and scored dichot-
omously. The CSI+ is an expansion of the Caregiver
Strain Index and also rates positive aspects of caring.
The CSI+ is proven valid and responsive [60–62].
Carer Quality of Life Scale (CarerQOL) The CarerQOL
is a valid instrument to evaluate care-related quality of
life in informal caregivers. The instrument consists of a
burden instrument (encompassing seven important bur-
den dimensions) and a valuation component (a VAS
scale for happiness). It consists of seven questions with
each three-answer options (no, some, a lot) and a VAS
scale (‘how happy are you at this moment?’) [63–65].
* Patient and caregiver
Hospital Anxiety and Depression Scale (HADS) The
HADS is a measure to evaluate mood: anxiety and de-
pression. The HADS consists of 14 items (seven anxiety
and seven depression), each with a 4-point rating scale
(0–3) It is a brief, reliable, responsive, valid and widely
used measure [33, 34].
Fatigue Severity Scale (FSS) The FSS measures the im-
pact of fatigue. It consists of nine items, and scores for
each item range from 1 to 7. The total FSS score is the
mean of the nine item scores. The FSS was validated
and demonstrated to be a simple and reliable instrument
to assess and quantify fatigue for clinical and research
purposes [66].
General Self-efficacy Scale The General Self-Efficacy
Scale is a valid 10-item psychometric scale that is de-
signed to assess optimistic self-beliefs to cope with a var-
iety of difficult demands in life. It has a 4-point rating
scale (‘not at all true’. ‘barely true’, ‘moderately true’ and
‘exactly true’). The scale has been originally developed in
German and has been used in many studies with hundred
thousands of participants. General self-efficacy is a
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universal construct that yields meaningful relations with
other psychological constructs [67, 68].
(Cost) Diaries Each patient-caregiver couple will be
asked to keep a weekly cost diary during 12 weeks. Dir-
ect and indirect cost data will be collected. The diary
will comprise questions for the patient on medical con-
sumption (for example questions about consultation
with doctors, therapists, re-admission, home care), miss-
ing hours at work, household, sports or hobbies and
time invested by the caregiver in the caregiver-mediated
training [69]. In addition, the patient will be asked to
record the exercises done each day during the eight-
week intervention period (in therapy, by themselves,
with nurses or with a caregiver). Thereby we can evalu-
ate the total time spent on (additional) exercises done by
the couples in the intervention and control group. Prob-
lems and adverse events like for example falls, fractures,
and concurrent illness will also be recorded.
Process analysis
At the end of the intervention, semi-structured inter-
views will be conducted with a subgroup of patients and
caregivers to collect qualitative data regarding the ex-
perience of CME to evaluate facilitators and barriers for
implementation.
Power analysis
We expect a significant reduction of five points (11 %)
on the SIS mobility domain in favor of the experimental
training group, with an estimated standard deviation for
this population at a maximum of 14 points [70], requir-
ing inclusion of minimally 30 patients per arm of the
trial. Including 10 % dropouts, a minimum of 66 stroke
patients, (i.e., 22 per type of center), is needed to achieve
a sufficient statistical power of 80 % using a significance
level alpha of p < 0.05.
Data analyses
Baseline characteristics will be presented and between
group differences will be studied to determine whether
groups are comparable at baseline. Normality of data dis-
tributions will be judged by visual plot. When data are not
normally distributed, non-parametric Wilcoxon signed
rank sum tests will be used. When the data are normally
distributed student t-tests for independent samples will be
used. The two-tailed α-level will be set at 0.05.
The main outcomes will be compared between the
intervention and control group at the different time
points using multilevel regression analysis. Depending
on the number of settings of participating centers we
will use random coefficient analysis (SPSS GLM). Time
since stroke, group, location and baseline values will be
added to the model. Intention-to-treat analysis will be
done and missing data will be imputed using multiple
imputation techniques. All hypotheses will be tested two
sided, with a critical value of <0.05.
Economic evaluation
The economic evaluation will be performed from a soci-
etal perspective and a health care perspective with a time
horizon of 12 weeks. For the measurement and valuation
of the costs the Dutch costing guidelines will be used
[71]. All relevant costs will be measured and valued, in-
cluding cost of production loss where applicable. The
analysis will be done according to the intention-to-treat
principle. Missing cost and effect data will be imputed
using multiple imputations according to the MICE (Mul-
tiple Imputation by Chained Equations) algorithm [72].
Bias-corrected and accelerated bootstrapping with 5000
replications will be used to calculate 95 % confidence inter-
vals around the mean difference in total costs between the
two groups. Incremental cost-effectiveness ratios (ICERs)
will be calculated by dividing the difference in mean total
costs by the difference in mean effects on the primary out-
comes (SIS mobility and LOS) between the treatment
groups. A cost-utility analysis will be performed estimating
the incremental costs per QALYs gained. In the costs
utility-analysis the outcome measure will be QALYs based
on the Dutch tariff for the EuroQol [56]. Bootstrapping will
be used to estimate the uncertainty surrounding the ICERs,
which will be graphically presented on cost-effectiveness
planes. Cost-effectiveness acceptability curves and net
monetary benefits will also be calculated. To estimate in-
direct costs of production loss the human capital approach
will be used. Sensitivity analyses will be performed on the
most important and uncertain cost parameters.
Discussion
The CARE4STROKE trial is the first observer-blinded
randomized clinical trial aimed to investigate the effect-
iveness of a CME program combined with e-health,
added to usual care, in terms of self-reported outcome
of mobility (SIS 3.0) and LOS in patients with stroke ad-
mitted to hospital stroke unit, rehabilitation center or
nursing home.
The main aspects of the CARE4STROKE program are
1) increasing intensity of training by doing exercises with
a caregiver in addition to usual care and 2) e-health
support.
A higher intensity of training improves functional out-
come after stroke [3, 10–16]. However only few studies
have been done in which a higher intensity of training is
achieved by CME [26, 29–31]. Moreover, none of these
existing studies investigated the cost-benefits of CME
and none combined CME with e-Health services. We
assume that e-health can support adherence to the
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program for patient and caregiver and promote self-
management [25, 73]. In this intervention e-health
consists of the CARE4STROKE tablet application, which
clearly explains the exercises through video instructions
and is simple and attractive to use. And, in addition to
this, tele-rehabilitation services are available such as tele-
phone, skype or email to contact the coordinating ther-
apist when appropriate.
We hypothesize that the combination of a weekly pro-
gressive, incremental training regimen done with a care-
giver together with continuing support of a therapist
through additional e-health services may enhance ESD
and increase feelings of QoL, perceived empowerment
and self-management of the patient - caregiver couple. As
a consequence, we expect that CARE4STROKE will lead
to a reduced LOS and will thereby reduce care costs.
Defining LOS should be done carefully, since it may
be influenced by non-medical factors that are not dir-
ectly related to the functional ability of the patient. Data
on additional factors which could also influence LOS
will be collected, like discharge destination, comorbidity,
the need for facilities at home, etc. [74]. We will also rec-
ord the planned discharge date and the real discharge
date. We will describe these data and, when necessary,
do subgroup analyses.
The optimal dose for caregiver-mediated exercises is not
yet known, few studies have been done [26–31]. We ask pa-
tients and caregivers to perform the selected set of exercises
minimally five times a week for 30 min. This dose was
chosen because it leads to a surplus of 150 min of exercise
a week, which is in line with recommendations of most
guidelines [15, 17–20] and proved to be feasible in our pilot
study.
Caregivers are more intensively involved in CME than
during usual care. At first glance, this could increase
caregiver strain. Other studies show no significant nega-
tive influence or even a decrease in caregiver strain in
the CME intervention group [26, 30]. It is suggested that
the latter effect arises due to more knowledge and ex-
perience of the caregiver about what the patient can and
cannot do. We will not only assess caregiver strain, but
also anxiety, depression, quality of life, fatigue and self-
efficacy of the caregiver, to closely monitor the effects of
our intervention on the caregiver.
CME will be implemented in three different rehabilitation
settings, i.e., hospital stroke units, rehabilitation centers and
nursing homes, to study its applicability and effectiveness in
different care settings. The inclusion criteria are liberally de-
fined, in order to get more insight in the type of patients
and caregivers that are eligible for CME and facilitators and
barriers for implementation. For example we will include
patients with MMSE > 18 [35] and patients and caregivers
with a HADS score on the domain ‘depression’ < 11 [33,
34], acknowledging that patients with some cognitive
decline and patients and caregivers with some depression
may benefit from our CARE4STROKE program. Probably a
major factor for successful implementation is that the pa-
tient and caregiver are physically and emotionally able and
willing to perform the exercises together. Therefore, an in-
take exercise session with the physical therapist is incorpo-
rated to judge whether patient and caregiver can adequately
perform the exercises together.
Interestingly, in a small-scale pilot study, about 25 % of
the eligible participants with stroke, did not have a willing
and/or able caregiver. We will keep track of inclusion-
rates and reasons for exclusion and will record how many
possible participants cannot continue because of a lack of
caregivers. This is relevant data in light of a trend in trans-
ferring care from professional to informal caregivers with
focus on self-management and has not been addressed in
previous RCTs on CME [26–31].
A limitation of our current design is that participants in
the control group continue with usual care but do not re-
ceive any (new) intervention. With that the trial is not dose-
matched. In addition, the adherence of the participants in-
cluded in the control group to fill in the diaries could be
low. Furthermore, in some centers, participants in control
and intervention groups are admitted to the same wards.
This could lead to contamination in the control group,
when patients and/or caregivers see how others exercise to-
gether. Finally, our selection criteria are liberally defined,
this could be a limitation of external validity. During the
training course, participating therapists are instructed to
pay specific attention to the diaries and dangers for con-
tamination to minimize these effects. A number of out-
come measures, including one of the primary outcome
measures (mobility domain of SIS 3.0), are self-reported. It
is impossible to blind the patient-caregiver couple, and
therefore these outcome measures are not blinded. How-
ever, a blinded outcome assessor assesses the other object-
ive outcome measures.
In conclusion: The CARE4STROKE study will be the
first clinical trial in which the effects and cost-
effectiveness of CME combined with e-health services to
enhance ESD is investigated. The first results are expected
early 2018.
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